Selected Grants
Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Mitigating Ischemia-Reperfusion Injury to Intestinal Allografts Using Normothermic Machine Perfusion
ResearchCo Investigator · Awarded by North Carolina State University · 2024 - 2028Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Gene therapy of discarded human kidney grafts during 48 hours ex-vivo machine perfusion
ResearchPrincipal Investigator · Awarded by Asklepios BioPharmaceutical, Inc. · 2021 - 2026Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2025Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Mitigating Ischemia-Reperfusion Injury to Intestinal Allografts Using Normothermic Machine Perfusion
ResearchCo Investigator · Awarded by North Carolina State University · 2024 - 2028Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Gene therapy of discarded human kidney grafts during 48 hours ex-vivo machine perfusion
ResearchPrincipal Investigator · Awarded by Asklepios BioPharmaceutical, Inc. · 2021 - 2026Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2025Therapeutic modulation of the complement system to minimize Ischemia Reperfusion Injury in a rat kidney transplant model
ResearchPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2024 - 2025Engineering Strategies for Replenishable Drug-Eluting Transplants
ResearchPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2023 - 2025NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements
ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2024 - 2025BMI Service Agreement
ResearchCo Investigator · Awarded by BioMedInnovations, LLC · 2021 - 2024Effects of storage method on intestinal allograft immune profile and viability
ResearchInvestigator · Awarded by Department of Defense · 2019 - 2024Liproxstatin- 2 As a Therapeutic to Mitigate Renal Ischemia-Reperfusion Injury in a Murine Model
FellowshipPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2023 - 2024Optimization of drug-loading of solid organs pre-transplantation
FellowshipPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2023 - 2023The Delivery of AAV Vector to Liver Allograft using Machine Perfusion System
ResearchPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2021 - 2022Proposal for preliminary proof of concept studies with Plasmin in transplantation
ResearchPrincipal Investigator · Awarded by Grifols USA, LLC · 2020 - 2022Targeting mitochondrial dysfunction and damage-associated molecular patterns to improve the function of high risk grafts in liver transplantation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022Use of Sirtuin-1 Activators to Mitigate Ischemia-Reperfusion Injury after Liver Transplantation
ResearchPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2020 - 2021ASTS Presidential Student Mentor Grant
FellowshipPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2019 - 2019External Relationships
- Biomedinnovations
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.